Neuropeptide effects on brain development.
Peptides which act as neurotransmitters or neuromodulators in the adult nervous system exert influences on brain development. Altering the levels of neuropeptide to which a developing animal is exposed produces a wide variety of physiological and behavioral effects which are apparent in adulthood. Many of the developmental effects involve neural systems in which the neuropeptide plays a role in the adult.
Handelmann
G E
GE
D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000254:growth & development*; D006892:Hydroxydopamines / Q000494:pharmacology; D007858:Learning / Q000187:drug effects; D009074:Melanocyte-Stimulating Hormones / Q000494:pharmacology; D008691:Methadone / Q000494:pharmacology; D008938:Mitosis / Q000187:drug effects; D009294:Narcotics / Q000494:pharmacology; D009434:Neural Pathways / Q000254:growth & development; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D009929:Organ Size / Q000187:drug effects; D016627:Oxidopamine; D010146:Pain / Q000503:physiopathology; D010455:Peptides / Q000494:pharmacology*; D011597:Psychomotor Performance / Q000187:drug effects; D051381:Rats; D012684:Sensory Thresholds / Q000187:drug effects; D013004:Somatostatin / Q000494:pharmacology; D013373:Substance P / Q000494:pharmacology; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
D006892:Hydroxydopamines; D009294:Narcotics; D018377:Neurotransmitter Agents; D010455:Peptides; D015116:5,7-Dihydroxytryptamine; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone; D016627:Oxidopamine; D000324:Adrenocorticotropic Hormone; D009074:Melanocyte-Stimulating Hormones; D008691:Methadone